MFG
IDXX icon

Mendota Financial Group’s Idexx Laboratories IDXX Stock Holding History

Mendota Financial Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6
Closed -$2.48K – 232
2024
Q4 		$2.48K Hold
6
– – ﹤0.01% 287
2024
Q3 		$3.03K Buy
+6
New +$2.92K ﹤0.01% 295

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Mendota Financial Group's IDXX Position: Q1 2025 in Review

Mendota Financial Group sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 6 shares — an estimated $2.48K sold.

Mendota Financial Group first reported a position in IDXX in Q3 2024 and held it in 2 quarters. The position peaked at $3.03K in Q3 2024. 1,142 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

  • Mendota Financial Group reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
  • Mendota Financial Group sold 6 Idexx Laboratories shares in Q1 2025, an estimated $2.48K.
  • Mendota Financial Group first reported a position in Idexx Laboratories in Q3 2024 and held it in 2 quarters.
  • Mendota Financial Group's Idexx Laboratories position peaked at $3.03K in Q3 2024.
  • 1,142 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Mendota Financial Group's 13F filing for Q1 2025, filed 22 Apr 2025.